surmount-1 tirzepatide trial obesity without diabetes SURMOUNT-1: Adults achieve weight loss of 16% or more at 72 weeks with SURMOUNT 1 // Three-Year Obesty

It helps your cells convert the carbohydrates, fats, and proteins you eat into usable fuel

Maintaining hydration and spacing doses helps reduce these effects

This broader view helps us understand not just retatrutide weight loss results from studies, but how any weight loss medication is shaping your overall health picture

Dehydration from gastrointestinal side effects represents one plausible indirect mechanism

Many of the current drug formulations available require injection, negatively influencing patients compliance to therapy, and present important side effects due to the ubiquitous distribution of the targeting receptors

It consistently leads to greater weight loss and offers additional benefits such as improved glycemic control and cardiovascular health